Structural and electrical remodeling as therapeutic targets in heart failure

被引:16
|
作者
Cutler, Michael J.
Rosenbaum, David S.
Dunlap, Mark E.
机构
[1] Heart and Vascular Research Center, Case Western Reserve University, Cleveland, OH, MetroHealth Campus
关键词
D O I
10.1016/j.jelectrocard.2007.05.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure is a progressive clinical syndrome that is characterized by remodeling of the myocardium in response to various stress signals. The past several years has seen remarkable progress in unraveling the molecular and cellular mechanisms of structural and electrical remodeling in HE Improved understanding of the molecular mechanism of myocardial remodeling has resulted in improved HF therapies and revealed potentially novel therapeutic targets. This review discusses the mechanisms of myocardial remodeling in HF and their clinical manifestations. Current and investigational HF therapies targeting these mechanisms also will be discussed. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:S1 / S7
页数:7
相关论文
共 50 条
  • [1] Electrical Remodeling in Heart Failure
    Tsuji, Yukiomi
    Kamiya, Kaichiro
    Kodama, Itsuo
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 45 : S4 - S4
  • [2] ELECTRICAL AND STRUCTURAL REMODELING IN HEART FAILURE AND PRESERVED EJECTION FRACTION WITH A PACEMAKER
    Omote, Kazunori
    Verbrugge, Frederik H.
    Sorimachi, Hidemi
    Omar, Massar
    Popovic, Dejana
    Obokata, Masaru
    Reddy, Yogesh N. V.
    Borlaug, Barry
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 362 - 362
  • [3] Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure
    Giuseppe Distefano
    Pietro Sciacca
    Italian Journal of Pediatrics, 38
  • [4] Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure
    Distefano, Giuseppe
    Sciacca, Pietro
    ITALIAN JOURNAL OF PEDIATRICS, 2012, 38
  • [5] Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure
    Freundt, Johanna K.
    Frommeyer, Gerrit
    Spieker, Tilmann
    Woetzel, Fabian
    Grotthoff, Jochen Schulze
    Stypmann, Joerg
    Hempel, Georg
    Schaefers, Michael
    Jacobs, Andreas H.
    Eckardt, Lars
    Lange, Philipp S.
    BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (1):
  • [6] Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs
    Shu-Sen, Yang
    Wei, Han
    Hong-Yan, Zhou
    Guo, Dong
    Bai-Chun, Wang
    Hong, Hijo
    Na, Wei
    Yong, Cao
    Guo, Zhou
    Chun-Hong, Xw
    Wei-Min, Li
    CHINESE MEDICAL JOURNAL, 2008, 121 (01) : 38 - 42
  • [7] Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs
    YANG Shusen HAN Wei ZHOU Hongyan DONG Guo WANG Baichun HUO Hong WEI Na CAO Yong ZHOU Guo XIU Chunhong and LI Weimin Department of CardiologyFirst Clinical College of Harbin Medical UniversityHarbinHeilongjiang China
    中华医学杂志(英文版), 2008, (01) : 38 - 42
  • [8] Histone deacetylase inhibition by Entinostat for the prevention of electrical and structural remodeling in heart failure
    Johanna K. Freundt
    Gerrit Frommeyer
    Tilmann Spieker
    Fabian Wötzel
    Jochen Schulze Grotthoff
    Jörg Stypmann
    Georg Hempel
    Michael Schäfers
    Andreas H. Jacobs
    Lars Eckardt
    Philipp S. Lange
    BMC Pharmacology and Toxicology, 20
  • [9] Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure
    Wakisaka, Y
    Niwano, S
    Niwano, H
    Saito, J
    Yoshida, T
    Hirasawa, S
    Kawada, H
    Izumi, T
    CARDIOVASCULAR RESEARCH, 2004, 63 (04) : 689 - 699
  • [10] Mitochondria as Therapeutic Targets in Heart Failure
    Julia Schwemmlein
    Christoph Maack
    Edoardo Bertero
    Current Heart Failure Reports, 2022, 19 : 27 - 37